Weiwei Zheng

5PUBLICATIONS
8CO-AUTHORS
Cancer cell biologyHaematological tumoursPredictive and prognostic markersNephrology and urology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Apr 11, 2026
CCDC137 stabilizes S100A6 to activate the PI3K/AKT pathway and drive acute myeloid leukemia progression.

Xiaoying Zhao, Wenjing Zhang, Sirui Chen

|Jan 29, 2026
DHCR7 drives AML development through the IL6/JAK2/STAT3 signalling pathway.

Xu Dai, Zhaoxing Wu, Wenjing Zhang

|Nov 06, 2025
DHCR7 as a Prognostic and Immunological Biomarker in Human Pan-Cancer: A Comprehensive Evaluation.

Xianghua Wu, Weiwei Zheng, Li Wang

|Dec 28, 2020
CaMKIIγ regulates the viability and self-renewal of acute myeloid leukaemia stem-like cells by the Alox5/NF-κB pathway.

Jiang-Hua Cheng, Wen-Jing Zhang, Jun-Feng Zhu

|Dec 02, 2020
Examination of Ureaplasma urealyticum and Mycoplasma hominis in 4082 Chinese patients.

Wei-Wei Zheng, Wen-Jing Zhang, Di Cui

Pageof 1